- Home
- ALTS vs LTRN Comparison
ALTS vs LTRN Comparison
Compare ALTS & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- LTRN
- Stock Information
- Founded
- ALTS 1976
- LTRN 2013
- Country
- ALTS United States
- LTRN United States
- Employees
- ALTS N/A
- LTRN N/A
- Industry
- ALTS
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- LTRN Health Care
- Exchange
- ALTS NYSE
- LTRN Nasdaq
- Market Cap
- ALTS 35.9M
- LTRN 35.4M
- IPO Year
- ALTS N/A
- LTRN 2020
- Fundamental
- Price
- ALTS $3.84
- LTRN $3.15
- Analyst Decision
- ALTS
- LTRN Hold
- Analyst Count
- ALTS 0
- LTRN 1
- Target Price
- ALTS N/A
- LTRN N/A
- AVG Volume (30 Days)
- ALTS 209.2K
- LTRN 77.7K
- Earning Date
- ALTS 12-27-2024
- LTRN 11-07-2024
- Dividend Yield
- ALTS N/A
- LTRN N/A
- EPS Growth
- ALTS N/A
- LTRN N/A
- EPS
- ALTS N/A
- LTRN N/A
- Revenue
- ALTS $7,110,000.00
- LTRN N/A
- Revenue This Year
- ALTS N/A
- LTRN N/A
- Revenue Next Year
- ALTS N/A
- LTRN N/A
- P/E Ratio
- ALTS N/A
- LTRN N/A
- Revenue Growth
- ALTS N/A
- LTRN N/A
- 52 Week Low
- ALTS $0.50
- LTRN $2.79
- 52 Week High
- ALTS $5.26
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- ALTS 68.94
- LTRN 42.56
- Support Level
- ALTS $3.33
- LTRN $3.10
- Resistance Level
- ALTS $4.00
- LTRN $3.60
- Average True Range (ATR)
- ALTS 0.35
- LTRN 0.43
- MACD
- ALTS 0.05
- LTRN -0.05
- Stochastic Oscillator
- ALTS 90.12
- LTRN 2.53
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.